Based on the mutually exclusive expression of TRBC1 and TRBC2, they developed anti-TRBC1 CAR-T cells that recognized and killed normal and malignant TRBC1+ but not TRBC2+ T cells in vitro and in a disseminated mouse model of leukemia. Here, TRBC1 is linked to leukemia.